StockViz
RANKINGS
BioLineRx Ltd.
Tel Aviv Stock Exchange:BLRX.TA
Sector
Industries
Location
Market Cap
USD 18.02 M
Share Price
USD 0.01
Avg Daily Volume
10,089,224
Change (1 day)
-4.24%
Change (1 year)
-85.30%
Change (YTD)
-58.18%
BioLineRx Ltd. Income Statement 2014 - 2024
This table shows the Income Statement for BioLineRx Ltd. going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.87
600276.SS
-0.17
-2.10%
Takeda Pharmaceutical Company Limited
USD 29.30
4502.T
-0.27
-0.91%